Literature DB >> 28888340

Proteomic analysis of influenza haemagglutinin-specific antibodies following vaccination reveals convergent immunoglobulin variable region signatures.

Penelope J Adamson1, Mahmood A Al Kindi2, Jing J Wang3, Alex D Colella4, Timothy K Chataway5, Nikolai Petrovsky6, Tom P Gordon7, David L Gordon8.   

Abstract

Analysis of the anti-haemagglutinin serum antibody proteome from six H1N1pdm09 influenza A vaccinated subjects demonstrated restricted IgG1 heavy chain species encoded by IGHV5-51 and IGHV3-7 gene families in 2 subjects and either IGHV5-51 or IGHV3-7 in 4 individuals. All subjects exhibited a dominant IGKV3-20 light chain, however 5 subjects also exhibited IGKV3-11 and IGKV4-1 families. Sequences were closely aligned with the matched germline sequence, with few shared mutations. This study illustrates the feasibility of using a proteomic approach to determine the expressed V region signatures of serum antibodies induced by vaccination.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Influenza A; Mass spectrometric sequencing; Proteomics; Serum antibody repertoire; Vaccination

Mesh:

Substances:

Year:  2017        PMID: 28888340     DOI: 10.1016/j.vaccine.2017.08.053

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  Precipitating anti-dsDNA peptide repertoires in lupus.

Authors:  J J Wang; A D Colella; D Beroukas; T K Chataway; T P Gordon
Journal:  Clin Exp Immunol       Date:  2018-10-11       Impact factor: 4.330

2.  Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion and ME/CFS.

Authors:  Milica Milivojevic; Xiaoyu Che; Lucinda Bateman; Aaron Cheng; Benjamin A Garcia; Mady Hornig; Manuel Huber; Nancy G Klimas; Bohyun Lee; Hyoungjoo Lee; Susan Levine; Jose G Montoya; Daniel L Peterson; Anthony L Komaroff; W Ian Lipkin
Journal:  PLoS One       Date:  2020-07-21       Impact factor: 3.240

3.  Convergent antibody evolution and clonotype expansion following influenza virus vaccination.

Authors:  David Forgacs; Rodrigo B Abreu; Giuseppe A Sautto; Greg A Kirchenbaum; Elliott Drabek; Kevin S Williamson; Dongkyoon Kim; Daniel E Emerling; Ted M Ross
Journal:  PLoS One       Date:  2021-02-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.